KDR and Hyperkeratosis: VEGFR blockade compromises the dermal microvasculature, while RAF/MAPK suppression heightens keratinocyte stress, so mechanical load tips the balance toward localized ischemic–inflammatory injury and hyperkeratosis—hallmarks of HFSR seen with sorafenib-class agents and relevant to donafenib (36).